Pharmaceutical Policy Reform in Spain
(2006; 4 pages)


There are many deficiencies in the operation of pharmaceutical policy in Spain. This article provides a brief overview of the way in which the market functions and highlights some structural problems. We describe and provide some insights on the main economic policy problems to be faced in the regulation of the Spanish market. Key measures introduced as part of new 2006 legislation intended to address some of these deficiencies are then discussed.

The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017